Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea

Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin® injection to be inactivated, after one year of follow-up.